摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Hydroxypyrazole;pyrimidine

中文名称
——
中文别名
——
英文名称
1-Hydroxypyrazole;pyrimidine
英文别名
1-hydroxypyrazole;pyrimidine
1-Hydroxypyrazole;pyrimidine化学式
CAS
——
化学式
C7H8N4O
mdl
——
分子量
164.16
InChiKey
PODPXEGNOSTZRY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    63.8
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • [EN] HISTONE DEMETHYLASE INHIBITORS<br/>[FR] INHIBITEURS DE L'HISTONE DÉMÉTHYLASE
    申请人:QUANTICEL PHARMACEUTICALS INC
    公开号:WO2014089364A1
    公开(公告)日:2014-06-12
    Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
    本文提供了替代嘧啶吡唑啉、嘧啶吡唑啉和嘧啶咪啉衍生物化合物以及包含这些化合物的药物组合物。这些化合物和组合物对于抑制组蛋白去甲基化酶具有用途。此外,这些化合物和组合物对于治疗癌症,如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等癌症有用。
  • HISTONE DEMETHYLASE INHIBITORS
    申请人:Quanticel Pharmaceuticals, Inc.
    公开号:US20140194469A1
    公开(公告)日:2014-07-10
    Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
    本文提供了代替的吡唑吡啶吡唑吡嗪吡唑嘧啶生物化合物及包含该化合物的药物组合物。该化合物和组合物可用于抑制组蛋白去甲基化酶。此外,该化合物和组合物可用于治疗癌症,如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等。
  • PYRIDINE-PYRAZOLE DERIVATIVES AS HISTONE DEMETHYLASE INHIBITORS
    申请人:Celgene Quanticel Research, Inc.
    公开号:EP3763367A1
    公开(公告)日:2021-01-13
    Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
    本文提供了取代的吡唑吡啶吡唑哒嗪吡唑嘧啶生物化合物以及包含上述化合物的药物组合物。上述化合物和组合物可用于抑制组蛋白去甲基化酶。此外,所述化合物和组合物还可用于治疗癌症,如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等。
  • Histone demethylase inhibitors
    申请人:CELGENE QUANTICEL RESEARCH, INC.
    公开号:US10173996B2
    公开(公告)日:2019-01-08
    Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
    本文提供了取代的吡唑吡啶吡唑哒嗪吡唑嘧啶生物化合物以及包含上述化合物的药物组合物。上述化合物和组合物可用于抑制组蛋白去甲基化酶。此外,所述化合物和组合物还可用于治疗癌症,如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等。
  • US8987461B2
    申请人:——
    公开号:US8987461B2
    公开(公告)日:2015-03-24
查看更多